BERGMANN JOHN E,CUTSHALL NEIL S,DEMOPULOS GREGORY A,FLORIO VINCENT A,GAITANARIS GEORGE,GRAY PATRICK,HOHMANN JOHN,ONRUST RENE,ZENG HONGKUI
申请号：
NZ59667210
公开号：
NZ596672A
申请日:
2010.05.03
申请国别(地区):
NZ
年份:
2014
代理人:
摘要：
Disclosed is the use of PDE7 inhibitors for treating a movement abnormality associated with the pathology of a neurological disorder in a patient. Specific examples of neurological movement disorders include Parkinson&rsquos disease, Post-Encephalitic Parkinsonism, Dopamine Responsive Dystonia, Shy-Drager Syndrome, Periodic Limb Movement Disorder (PLMD), Periodic Limb Movements in Sleep (PLMS), Tourette&rsquos Syndrome, and Restless Leg(s) Syndrome (RLS).
